Anthony J. Shuker, PhD

---

Tony Shuker is experienced in the science and the business of drug discovery and development and has seen the highs and lows of both. His career as a synthetic and medicinal chemist has yielded numerous patents in the United States and abroad, as well as several molecules in clinical development. His work as an advocate of the biotechnology industry has helped to establish several independent research and development companies. Dr. Shuker was formerly a senior scientist at Eli Lilly and Company in Indianapolis, where he had responsibility for leading a number of major drug discovery and development projects that resulted in multiple clinical candidates. While at Lilly, he led a team that brought a compound to clinical trial in 212 days, the fastest "time to trial" for a compound in the company's history. Following his pharmaceutical career, Dr. Shuker has been involved in a number of entrepreneurial ventures and served as president of the privately held NuTec Life Sciences and EmTech Bioscience. He was part of the executive management team of Somatocor Pharmaceuticals and founded Prism Therapeutics. Most recently, Dr. Shuker was founder and CEO of Metastatix. Dr. Shuker serves on the Board of Georgia Bio and is an Advisor to the Emerging Leaders Network. Because of his dual perspective as both scientist and entrepreneur, Shuker has been in high demand as a speaker, addressing dozens of conferences and organizations. He has a First Class Honors degree from the University of Bath and a Ph.D. from the University of Nottingham in the group of Prof. Gerry Pattenden (FRS). Dr. Shuker has also served as a SERC/NATO Research Fellow at Stanford in the lab of Paul Wender, where he worked on the total synthesis of Taxol. Dr. Shuker lives in Metro Atlanta and has two Daughters, Molli and Lucy. He owns an undisclosed number of guitars and was once mistaken for Russell Crowe.